About: Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1988

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1988 (uk) im Januar 1988 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1988 (ast) artikull shkencor i botuar më 01 janar 1988 (sq) scientific article published on 01 January 1988 (en)
publication date	wds:Q68094892-47ACB830-5DA1-4756-9B91-718D72216C29
publication date	1988-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q68094892-E2EA6251-2C5F-4828-9F9D-950B032A01C1
exact match	https://scigraph.springernature.com/pub.10.1007/bf00199937
cites work	wds:Q68094892-07DC4F2C-A9CA-4942-8299-4F5119403CF4 wds:Q68094892-14CAD9D7-3055-4B9D-8F82-669B6736392F wds:Q68094892-162D483B-DEE9-40D5-818A-60D03C80FEDC wds:Q68094892-33F5E15A-F9F1-479E-A644-CB1F6AA380CC wds:Q68094892-35DF81D6-C1B1-4360-AE19-05185AF55396 wds:Q68094892-3923F2E4-A018-4416-9C82-5A85CF3F9974 wds:Q68094892-3BD22FE8-6F74-441A-BA2E-99952A486D15 wds:Q68094892-3E428943-C734-4D25-936D-CE29CDF680AC wds:Q68094892-400860EB-BBF5-468C-B9B1-2F9733DC62AB wds:Q68094892-53E8EE62-F807-4B0E-B092-3B2B4D972FD7 wds:Q68094892-57B63509-BDFB-439A-8FBD-1F0BE8F9567E wds:Q68094892-57CEB990-BE95-4D51-86A7-482E332F120C wds:Q68094892-6FCEDD88-00CA-43C0-AFE6-D8C045CF11E2 wds:Q68094892-7696AE8C-2B5D-497B-855A-EEC8D4C67F2A wds:Q68094892-7CCB894F-9611-4014-9125-CD7A4F20E9E6 wds:Q68094892-8E665070-D4BA-4E57-9261-1CCA53600F50 wds:Q68094892-8F91C61C-AB37-4264-8BAB-1E73EA75496A wds:Q68094892-94D301A4-C0AE-46C9-A938-9AAFF8217101 wds:Q68094892-96391A86-DE7D-44AF-B492-D663C933C523 wds:Q68094892-975A0ACB-1E4A-4872-A294-F1B1F79E013E wds:Q68094892-A2AF8000-D591-44D4-8D9F-922FB62EFD13 wds:Q68094892-B23906AF-82AC-4D81-A9E7-7F90604D641E wds:Q68094892-B2DDB98D-9B50-47C1-AB4E-21663D3C8A8F wds:Q68094892-CA4F357D-CC89-41C5-B753-3D151107DE73 wds:Q68094892-D1EF0D8F-7F00-48FD-B04B-F20874AE4286 wds:Q68094892-D2E3CEC7-6B30-4742-B37E-A2F992B53107 wds:Q68094892-D6C66E21-0237-4EA8-BE39-82033A802C95 wds:Q68094892-D74ACEFC-7C74-433D-AA62-A1ED3D204909 wds:Q68094892-E00EFCA5-BE66-4A49-92C2-53243EF8ED29 wds:Q68094892-EB54CDA5-C682-4E79-9C23-B9C2061F8ADC wds:Q68094892-EC452CDB-CF2A-4936-8BD4-17986CC63F3B
cites work	Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. The fate of interleukin-2 after in vivo administration Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2 Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2. Molecular cloning of human interleukin 2 cDNA and its expression inE. coli Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma Enhancement of therapeutic effects of recombinant interleukin 2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors. Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2 Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide Effect of Chemotherapeutic Agents on Natural Cell-Mediated Cytotoxicity in Mice2 Enhancement of antitumor transplantation resistance in rats by appropriately timed administration of busulfan. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats The therapeutic effect of the antileukemia drug busulfan as an immunomodulator on transplanted fibrosarcoma KMT-17 in WKA rats Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin A Elimination of tumor-enhancing cells by cyclophosphamide and its relevance to cyclophosphamide therapy of the murine mammary tumor Effect of antineoplastic agents on the induction of suppressor macrophages by concanavalin A-bound tumor vaccine
author name string	wds:Q68094892-04720B46-0E8B-413D-B6FD-E74F9B9E8510 wds:Q68094892-520CD1BF-E735-4C51-A28C-70D52971B162 wds:Q68094892-54448737-0FEF-416D-95E6-1034DAF6AFD5 wds:Q68094892-5C1E5264-00FC-42B4-BFA7-C91FF74694BE wds:Q68094892-6E914662-4A8C-420D-9CFC-DA3F1673CF07 wds:Q68094892-8416B99C-24C0-4624-9369-01296D72B553 wds:Q68094892-D4114487-6D37-450B-A746-48FB070D6FD5
author name string	H Kobayashi K Itoh K Morikawa M Hosokawa Z Y Xu Y Sawamura T Morikage
rdfs:label	Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (en) Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (nl) Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (sq)
skos:prefLabel	Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (en) Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (nl) Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (sq)
name	Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (en) Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (nl) Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (sq)
author	wds:Q68094892-9C33BC89-3B3C-46DC-AA8A-6203CB20E579
author	Futoshi Okada
title	wds:Q68094892-A5BC8A89-2665-4174-8F27-5A8378DA3494
title	Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software